Schedule 13G ownership disclosure

Intec Pharma Ltd.

Security class unavailable · CUSIP: M53644106

Event date: 2020-05-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,000,000
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-060584
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
May 13, 2020
Reporting period
May 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub